Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk

In conclusion, systemic administration of rhNRG-1 in hypercholesterolemic type 1 diabetic mice simultaneously protects against complications in the heart, arteries and kidneys.

Source: AJP: Endocrinology and Metabolism - March 31, 2016 Category: Endocrinology Authors: Vandekerckhove, L., Vermeulen, Z., Liu, Z. Z., Boimvaser, S., Patzak, A., Segers, V. F. M., De Keulenaer, G. W. Tags: Articles Source Type: research